These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12766598)

  • 1. Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
    Dierickx LO; Everaert H; Deron P; Voordeckers M; Lahoutte T; Bossuyt A
    Nucl Med Commun; 2003 Jun; 24(6):633-41. PubMed ID: 12766598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
    Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
    Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
    Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-123 alpha-methyl-l-tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas.
    Flamen P; Bernheim N; Deron P; Caveliers V; Chavatte K; Franken PR; Bossuyt A
    Eur J Nucl Med; 1998 Feb; 25(2):177-81. PubMed ID: 9473267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.
    Plotkin M; Wurm R; Kuczer D; Wust P; Michel R; Denecke T; Ruf J; Schlenger L; Bischoff A; Felix R; Amthauer H
    Onkologie; 2006 Apr; 29(4):147-52. PubMed ID: 16601370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
    Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
    Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
    Henze M; Mohammed A; Mier W; Rudat V; Dietz A; Nollert J; Eisenhut M; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):324-30. PubMed ID: 12002706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
    Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
    Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
    J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
    Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
    Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
    Jager PL; Groen HJ; van der Leest A; van Putten JW; Pieterman RM; de Vries EG; Piers DA
    J Nucl Med; 2001 Apr; 42(4):579-85. PubMed ID: 11337545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 201 Tl- with 67 Ga single photon emission tomography in the diagnosis of head and neck cancer recurrence.
    Yamamoto Y; Nishiyama Y; Toyama Y; Ohbayashi Y; Iwasaki A; Satoh K; Ohkawa M
    Nucl Med Commun; 2002 Feb; 23(2):187-91. PubMed ID: 11891475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.
    Lee JK; Tyan YS; Huang WS
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):528-31. PubMed ID: 14722682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
    Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
    Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
    Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
    Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of SPET and PET in monitoring tumour response to therapy.
    Giannopoulou C
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1173-200. PubMed ID: 12811421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.
    Kostakoglu L; Uysal U; Ozyar E; Demirkazik FB; Hayran M; Atahan L; Bekdik CF
    Eur J Nucl Med; 1997 Jun; 24(6):621-8. PubMed ID: 9169568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.